Value through Innovation27 July 2016

Clinical Study Results

  • ACTILYSE ® - Stroke
    Clinical Study Number 135.312
    Study Indication Stroke
    Product ACTILYSE ®
    Generic Name Alteplase
    Lab Code
    Clinical Phase IIIb
    Study Title

    ECASS III – European Cooperative Acute Stroke Study III: A placebo controlled trial of alteplase in acute ischemic hemispheric stroke where thrombolysis is initiated between 3 and 4 hours 30 minutes after stroke onset.

    Study Document Trial synopsis 135.312_CO english
  • ACTILYSE ® - Stroke
    Clinical Study Number 135.313
    Study Indication Stroke
    Product ACTILYSE ®
    Generic Name Alteplase
    Lab Code
    Clinical Phase IV
    Study Title

    Safe implements of Thrombolysis in Stroke -MOnitoring STudy (SITS-MOST)

    Study Document Trial synopsis 135.313_CO english
  • ACTILYSE ® - Stroke
    Clinical Study Number 135.315
    Study Indication Stroke
    Product ACTILYSE ®
    Generic Name Alteplase
    Lab Code
    Clinical Phase IV
    Study Title

    Actilyse PMS study final report

    Study Document Trial synopsis 135.315_CO english
  • ACTILYSE ® - Myocardial Infarction
    Clinical Study Number 135.301
    Study Indication Myocardial Infarction
    Product ACTILYSE ®
    Generic Name Alteplase
    Lab Code
    Clinical Phase IV
    Study Title

    A multicentre, feasibility study of pre-hospital treatment of acute myocardial infarction based on diagnosis by interpretation of remotely acquired ECG and thrombolysis with accelerated alteplase (Actilyse®). Pre-Hospital Alteplase Remote Advice Of Hospital (PHARAOH)

    Study Document Trial synopsis 135.301 english
  • ACTILYSE ® - Stroke
    Clinical Study Number 135.317
    Study Indication Stroke
    Product ACTILYSE ®
    Generic Name Alteplase
    Lab Code
    Clinical Phase IV
    Study Title

    SITS-NEW Safe Implementation of Thrombolysis in Stroke in the Non EUWorld: An International observational study of the Safety and Efficacy of Thrombolysis in stroke

    Study Document Trial synopsis 135.317 english
  • ACTILYSE ® - Catheter Obstruction
    Clinical Study Number 135.323
    Study Indication Catheter Obstruction
    Product ACTILYSE ®
    Generic Name Alteplase
    Lab Code
    Clinical Phase III
    Study Title

    A multicenter, open-label, randomised, clinical trial to compare the efficacy and safety of Actilyse® 2 mg/ 2 ml versus saline solution in restoring function of an occluded central venous access device

    Study Document Trial synopsis 135.323_DR english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.